Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Gold Price Monitor -- Ignore unavailable to you. Want to Upgrade?

To: lorne who wrote (68134)	4/23/2001 12:05:13 PM
From: Rarebird	Respond to of 116764

U.S. on alert for smallpox terror attack Monday, April 23, 2001 09:35 AM EDT LONDON, Apr 23, 2001 (United Press International via COMTEX) -- The U.S. government has ordered 40 million doses of smallpox vaccine from a British company in a sign of the growing alarm that terrorists could unleash lethal viruses in future battles against Western states, The Independent of London reported Monday. The vaccine is being manufactured by a U.S. subsidiary of the Cambridge-based U.K. biotechnology company Acambis, formerly known as Peptide Therapeutics. Delivery to the U.S. government's Center for Disease Control in Atlanta is due to start from mid-2004, the report said. "At the moment we are going through the process of developing and licensing the vaccine, but under the contract we have the right to sell it to anyone who wants it," a company spokeswoman said. "When the time comes we will be marketing it to other governments, including the United Kingdom. It certainly would be a logical step for them to take." If a virus such as smallpox was released, the speed of modern communications could spread the infection all over the world in days. The latest contract for smallpox vaccine is against a disease that no longer exists. It was eradicated from the planet in 1980 and only two research institutions -- one in the US and one in Russia --still retain stocks of the virus. Copyright 2001 by United Press International. News provided by COMTEX comtexnews.com